| Deler fremragende | 48,596,817 shares |
| Insideraktier | 34.037.444 shares |
| Insider ejerskab | 70,04 % |
| Total Insiders | 46 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Werewolf Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Arkin Bio Ventures 2 L.P.
10% Owner -
|
2.046.634 | 2.046.634 | |
|
Arkin Bio Ventures GPGP Ltd.
10% Owner -
|
2.046.634 | 2.046.634 | |
|
Moshe Arkin
10% Owner -
|
2.046.634 | 2.046.634 | |
|
Sakae Asanuma
Director, 10% Owner -
[D]
|
2.068.909 | 2.068.909 | |
| Atkins Michael B. Director - [D] | 14.419 | 14.419 | |
| Meeta Chatterjee | 23.200 | ||
|
Management Co Deerfield
10% Owner -
|
2.552.787 | 2.552.787 | |
|
Deerfield Partners, L.p.
10% Owner -
|
2.552.787 | 2.552.787 | |
|
Deerfield Mgmt L.P.
10% Owner -
|
2.552.787 | 2.552.787 | |
| Luke Evnin Director - [D] | 1.953.949 | 1.953.949 | |
|
James E Flynn
10% Owner -
|
2.552.787 | 2.552.787 | |
|
Todd Foley
10% Owner -
|
3.187.998 | 3.208.793 | |
| Ansbert Gadicke - | 4.784.111 | 4.784.111 | |
|
HBM Healthcare Investments (Cayman) Ltd.
10% Owner -
|
625.995 | 625.995 | |
|
Daniel J Hicklin
See Remarks, Director, 10% Owner -
[D]
[O]
|
647.047 | 647.047 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Randi Isaacs | 79.516 | ||
| Chulani Karunatilake | 34.258 | ||
|
Peter Kolchinsky
Director, 10% Owner -
[D]
|
4.291.881 | 6.681.307 | |
|
Alon Lazarus
Director, 10% Owner -
[D]
|
2.046.634 | 2.046.634 | |
| Reid Leonard Chief Operating Officer - [O] | 14.102 | 14.102 | |
|
Longwood Fund III GP, LLC
10% Owner -
|
1.677.082 | 1.677.082 | |
|
Longwood Fund III, L.P.
10% Owner -
|
1.677.082 | 1.677.082 | |
| Ellen Lubman | 51.088 | ||
|
MPM Asset Management Investors BV2014 LLC
10% Owner -
|
3.187.998 | 4.784.111 | |
|
MPM BioVentures 2014 (B), L.P.
10% Owner -
|
3.187.998 | 4.784.111 | |
|
MPM BioVentures 2014 GP LLC
10% Owner -
|
3.187.998 | 4.784.111 | |
|
MPM BioVentures 2014 LLC
10% Owner -
|
3.187.998 | 4.784.111 | |
| MPM BioVentures 2014, L.P. - | 4.784.111 | 4.784.111 | |
|
Mpm Oncology Innovations Fund Lp
10% Owner -
|
6.672.183 | 4.784.111 | |
|
MPM Oncology Impact Management GP LLC
10% Owner -
|
6.672.183 | 6.672.183 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
MPM Oncology Impact Management LP
10% Owner -
|
6.672.183 | 4.784.111 | |
|
MPM Oncology Innovations Fund GP LLC
10% Owner -
|
6.672.183 | 4.784.111 | |
| Briggs Morrison Director - [D] | 15.523 | 15.523 | |
|
Oncology Impact Fund (Cayman) Management L.P.
10% Owner -
|
6.672.183 | 4.784.111 | |
|
Ra Capital Management, Llc
Director, 10% Owner -
[D]
|
6.681.307 | 6.681.307 | |
|
RA Capital Healthcare Fund LP
Director, 10% Owner -
[D]
|
4.291.881 | 6.681.307 | |
|
Sphera Funds Management Ltd.
10% Owner -
|
787.997 | 787.997 | |
| Cynthia Seidel-Dugan Chief Scientific Officer - [O] | 164.888 | 164.888 | |
|
Shah Rajeev M.
Director, 10% Owner -
[D]
|
4.291.881 | 6.681.307 | |
|
Sphera Global Healthcare GP Ltd.
10% Owner -
|
787.997 | 787.997 | |
|
Sphera Global Healthcare Management LP
10% Owner -
|
787.997 | 787.997 | |
|
Taiho Ventures LLC
10% Owner -
|
2.068.909 | 2.068.909 | |
| Trost Timothy W. | 65.960 | ||
|
UBS Oncology Impact Fund L.P.
10% Owner -
|
6.672.183 | 4.784.111 | |
|
Upmc
10% Owner -
|
1.097.756 | 1.097.756 | |
| Urban Michael J. VP of Finance & Corp. Contr. - [O] | 5.284 | 5.284 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HOWL / Werewolf Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HOWL / Werewolf Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 2026-04-29 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6900 | -56.559 | -39 | 1.953.949 | ||||
| 2026-04-29 | 2026-04-28 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,7300 | -95.412 | -70 | 2.010.508 | ||||
| 2026-04-29 | 2026-04-27 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,8500 | -53.940 | -46 | 2.105.920 | ||||
| 2026-03-13 | 3 | Urban Michael J. | HOWL | Common Stock | D | 5.284 | ||||||||
| 2026-01-20 | 2026-01-16 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,5400 | -38.782 | -21 | 2.159.860 | ||||
| 2026-01-15 | 2026-01-15 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,5500 | -37.413 | -21 | 2.198.642 | ||||
| 2026-01-15 | 2026-01-14 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,5700 | -30.616 | -17 | 2.236.055 | ||||
| 2026-01-15 | 2026-01-13 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,5500 | -43.198 | -24 | 2.266.671 | ||||
| 2026-01-12 | 2026-01-12 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,5700 | -58.980 | -34 | 2.309.869 | ||||
| 2026-01-12 | 2026-01-09 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6100 | -24.678 | -15 | 2.368.849 | ||||
| 2026-01-12 | 2026-01-08 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6300 | -7.716 | -5 | 2.393.527 | ||||
| 2026-01-07 | 2026-01-07 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6400 | -11.915 | -8 | 2.401.243 | ||||
| 2026-01-07 | 2026-01-06 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6500 | -40.761 | -26 | 2.413.158 | ||||
| 2026-01-07 | 2026-01-05 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6400 | -18.378 | -12 | 2.453.919 | ||||
| 2026-01-02 | 2026-01-02 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6300 | -18.568 | -12 | 2.472.297 | ||||
| 2026-01-02 | 2025-12-31 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6200 | -24.962 | -15 | 2.490.865 | ||||
| 2026-01-02 | 2025-12-30 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6100 | -34.847 | -21 | 2.515.827 | ||||
| 2025-12-29 | 2025-12-29 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6100 | -108.606 | -66 | 2.550.674 | ||||
| 2025-12-29 | 2025-12-26 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6300 | -35.632 | -22 | 2.659.280 | ||||
| 2025-12-29 | 2025-12-24 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6500 | -16.310 | -11 | 2.694.912 | ||||
| 2025-12-29 | 2025-12-23 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6300 | -71.428 | -45 | 2.711.222 | ||||
| 2025-12-29 | 2025-12-22 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,6900 | -59.307 | -41 | 2.782.650 | ||||
| 2025-12-17 | 2025-12-17 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,1400 | -9.983 | -11 | 2.841.957 | ||||
| 2025-12-17 | 2025-12-16 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,0500 | -14.548 | -15 | 2.851.940 | ||||
| 2025-12-17 | 2025-12-15 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,0700 | -23.640 | -25 | 2.866.488 | ||||
| 2025-12-12 | 2025-12-12 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,0800 | -17.858 | -19 | 2.890.128 | ||||
| 2025-12-12 | 2025-12-11 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,0700 | -28.009 | -30 | 2.907.986 | ||||
| 2025-12-12 | 2025-12-10 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,0600 | -37.104 | -39 | 2.935.995 | ||||
| 2025-12-09 | 2025-12-09 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,0100 | -44.570 | -45 | 2.973.099 | ||||
| 2025-12-09 | 2025-12-08 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9900 | -34.041 | -34 | 3.017.669 | ||||
| 2025-12-09 | 2025-12-05 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9700 | -16.568 | -16 | 3.051.710 | ||||
| 2025-12-04 | 2025-12-04 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9700 | -53.416 | -52 | 3.068.278 | ||||
| 2025-12-04 | 2025-12-03 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,8700 | -36.726 | -32 | 3.121.694 | ||||
| 2025-12-04 | 2025-12-02 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,8900 | -38.043 | -34 | 3.158.420 | ||||
| 2025-12-04 | 2025-12-04 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9700 | -83.230 | -81 | 4.784.111 | ||||
| 2025-12-04 | 2025-12-03 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,8700 | -57.225 | -50 | 4.867.341 | ||||
| 2025-12-04 | 2025-12-02 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,8900 | -59.277 | -53 | 4.924.566 | ||||
| 2025-12-04 | 2025-12-04 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9700 | -83.230 | -81 | 4.784.111 | ||||
| 2025-12-04 | 2025-12-03 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,8700 | -57.225 | -50 | 4.867.341 | ||||
| 2025-12-04 | 2025-12-02 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,8900 | -59.277 | -53 | 4.924.566 | ||||
| 2025-12-01 | 2025-12-01 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9400 | -39.096 | -37 | 3.196.463 | ||||
| 2025-12-01 | 2025-11-28 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9900 | -13.014 | -13 | 3.235.559 | ||||
| 2025-12-01 | 2025-11-26 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9800 | -38.978 | -38 | 3.248.573 | ||||
| 2025-12-01 | 2025-12-01 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9400 | -60.917 | -57 | 4.983.843 | ||||
| 2025-12-01 | 2025-11-28 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9900 | -20.277 | -20 | 5.044.760 | ||||
| 2025-12-01 | 2025-11-26 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9800 | -60.733 | -60 | 5.065.037 | ||||
| 2025-12-01 | 2025-12-01 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9400 | -60.917 | -57 | 4.983.843 | ||||
| 2025-12-01 | 2025-11-28 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9900 | -20.277 | -20 | 5.044.760 | ||||
| 2025-12-01 | 2025-11-26 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9800 | -60.733 | -60 | 5.065.037 | ||||
| 2025-11-25 | 2025-11-25 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9200 | -27.297 | -25 | 3.287.551 | ||||
| 2025-11-25 | 2025-11-24 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9800 | -56.992 | -56 | 3.314.848 | ||||
| 2025-11-25 | 2025-11-21 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,8300 | -41.287 | -34 | 3.371.840 | ||||
| 2025-11-25 | 2025-11-25 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9200 | -42.533 | -39 | 5.125.770 | ||||
| 2025-11-25 | 2025-11-24 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9800 | -88.802 | -87 | 5.168.303 | ||||
| 2025-11-25 | 2025-11-21 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,8300 | -64.331 | -53 | 5.257.105 | ||||
| 2025-11-25 | 2025-11-25 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9200 | -42.533 | -39 | 5.125.770 | ||||
| 2025-11-25 | 2025-11-24 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9800 | -88.802 | -87 | 5.168.303 | ||||
| 2025-11-25 | 2025-11-21 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,8300 | -64.331 | -53 | 5.257.105 | ||||
| 2025-11-20 | 2025-11-20 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,8900 | -26.411 | -24 | 3.413.127 | ||||
| 2025-11-20 | 2025-11-19 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9400 | -42.566 | -40 | 3.439.538 | ||||
| 2025-11-20 | 2025-11-18 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9300 | -33.776 | -31 | 3.482.104 | ||||
| 2025-11-20 | 2025-11-20 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,8900 | -41.152 | -37 | 5.321.436 | ||||
| 2025-11-20 | 2025-11-19 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9400 | -66.324 | -62 | 5.362.588 | ||||
| 2025-11-20 | 2025-11-18 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9300 | -52.627 | -49 | 5.428.912 | ||||
| 2025-11-20 | 2025-11-20 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,8900 | -41.152 | -37 | 5.321.436 | ||||
| 2025-11-20 | 2025-11-19 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9400 | -66.324 | -62 | 5.362.588 | ||||
| 2025-11-20 | 2025-11-18 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9300 | -52.627 | -49 | 5.428.912 | ||||
| 2025-11-17 | 2025-11-17 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9500 | -36.621 | -35 | 3.515.880 | ||||
| 2025-11-17 | 2025-11-14 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9300 | -39.560 | -37 | 3.552.501 | ||||
| 2025-11-17 | 2025-11-13 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 0,9800 | -58.372 | -57 | 3.592.061 | ||||
| 2025-11-17 | 2025-11-17 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9500 | -57.061 | -54 | 5.481.539 | ||||
| 2025-11-17 | 2025-11-14 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9300 | -61.640 | -57 | 5.538.600 | ||||
| 2025-11-17 | 2025-11-13 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 0,9800 | -90.951 | -89 | 5.600.240 | ||||
| 2025-11-17 | 2025-11-17 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9500 | -57.061 | -54 | 5.481.539 | ||||
| 2025-11-17 | 2025-11-14 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9300 | -61.640 | -57 | 5.538.600 | ||||
| 2025-11-17 | 2025-11-13 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 0,9800 | -90.951 | -89 | 5.600.240 | ||||
| 2025-11-12 | 2025-11-12 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,0900 | -26.101 | -28 | 3.650.433 | ||||
| 2025-11-12 | 2025-11-11 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,1400 | -35.818 | -41 | 3.676.534 | ||||
| 2025-11-12 | 2025-11-10 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,1800 | -31.172 | -37 | 3.712.352 | ||||
| 2025-11-12 | 2025-11-07 | 4 | EVNIN LUKE See Footnotes | HOWL | Common Stock | I | 1,1100 | -43.950 | -49 | 3.743.524 | ||||
| 2025-11-12 | 2025-11-12 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 1,0900 | -40.669 | -44 | 5.691.191 | ||||
| 2025-11-12 | 2025-11-11 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 1,1400 | -55.810 | -64 | 5.731.860 | ||||
| 2025-11-12 | 2025-11-10 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 1,1800 | -48.570 | -57 | 5.787.670 | ||||
| 2025-11-12 | 2025-11-07 | 4 | MPM BioVentures 2014, L.P. See Footnotes | HOWL | Common Stock | I | 1,1100 | -68.480 | -76 | 5.836.240 | ||||
| 2025-11-12 | 2025-11-12 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 1,0900 | -40.669 | -44 | 5.691.191 | ||||
| 2025-11-12 | 2025-11-11 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 1,1400 | -55.810 | -64 | 5.731.860 | ||||
| 2025-11-12 | 2025-11-10 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 1,1800 | -48.570 | -57 | 5.787.670 | ||||
| 2025-11-12 | 2025-11-07 | 4 | GADICKE ANSBERT See Footnotes | HOWL | Common Stock | I | 1,1100 | -68.480 | -76 | 5.836.240 | ||||
| 2025-11-06 | 2025-11-06 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,2100 | -34.947 | -42 | 3.787.474 | ||||
| 2025-11-06 | 2025-11-05 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,2200 | -30.774 | -38 | 3.822.421 | ||||
| 2025-11-06 | 2025-11-04 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,2200 | -90.164 | -110 | 3.853.195 | ||||
| 2025-11-06 | 2025-11-06 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,2100 | -54.452 | -66 | 5.904.720 | ||||
| 2025-11-06 | 2025-11-05 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,2200 | -47.950 | -58 | 5.959.172 | ||||
| 2025-11-06 | 2025-11-04 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,2200 | -140.488 | -171 | 6.007.122 | ||||
| 2025-11-06 | 2025-11-06 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,2100 | -54.452 | -66 | 5.904.720 | ||||
| 2025-11-06 | 2025-11-05 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,2200 | -47.950 | -58 | 5.959.172 | ||||
| 2025-11-06 | 2025-11-04 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,2200 | -140.488 | -171 | 6.007.122 | ||||
| 2025-11-03 | 2025-11-03 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,2900 | -60.369 | -78 | 3.943.359 | ||||
| 2025-11-03 | 2025-10-31 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,2800 | -73.192 | -94 | 4.003.728 | ||||
| 2025-11-03 | 2025-10-30 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,4300 | -55.795 | -80 | 4.076.920 | ||||
| 2025-11-03 | 2025-11-03 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,2900 | -94.063 | -121 | 6.147.610 | ||||
| 2025-11-03 | 2025-10-31 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,2800 | -114.044 | -146 | 6.241.673 | ||||
| 2025-11-03 | 2025-10-30 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,4300 | -86.936 | -124 | 6.355.717 | ||||
| 2025-11-03 | 2025-11-03 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,2900 | -94.063 | -121 | 6.147.610 | ||||
| 2025-11-03 | 2025-10-31 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,2800 | -114.044 | -146 | 6.241.673 | ||||
| 2025-11-03 | 2025-10-30 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,4300 | -86.936 | -124 | 6.355.717 | ||||
| 2025-10-29 | 2025-10-29 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,5500 | -134.240 | -208 | 6.442.653 | ||||
| 2025-10-29 | 2025-10-28 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,6400 | -69.068 | -113 | 6.576.893 | ||||
| 2025-10-29 | 2025-10-27 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,7200 | -72.709 | -125 | 6.645.961 | ||||
| 2025-10-29 | 2025-10-29 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,5500 | -86.154 | -134 | 4.132.715 | ||||
| 2025-10-29 | 2025-10-28 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,6400 | -44.327 | -73 | 4.218.869 | ||||
| 2025-10-29 | 2025-10-27 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,7200 | -46.664 | -80 | 4.263.196 | ||||
| 2025-10-29 | 2025-10-29 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,5500 | -134.240 | -208 | 6.442.653 | ||||
| 2025-10-29 | 2025-10-28 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,6400 | -69.068 | -113 | 6.576.893 | ||||
| 2025-10-29 | 2025-10-27 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,7200 | -72.709 | -125 | 6.645.961 | ||||
| 2025-05-14 | 2025-05-14 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 0,9800 | 162.539 | 159 | 6.237.482 | ||||
| 2025-05-14 | 2025-05-13 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 0,9800 | 52.974 | 52 | 6.074.943 | ||||
| 2025-05-14 | 2025-05-12 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 0,8600 | 320.913 | 276 | 6.021.969 | ||||
| 2025-04-30 | 2025-03-27 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 1,0500 | -1.963 | -2 | 3.208.793 | ||||
| 2025-04-30 | 2025-03-27 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 0,0900 | 22.758 | 2 | 3.210.756 | ||||
| 2025-04-30 | 2025-03-27 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 1,0500 | -2.425 | -3 | 4.309.860 | ||||
| 2025-04-30 | 2025-03-27 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 0,0900 | 28.113 | 3 | 4.312.285 | ||||
| 2025-04-30 | 2025-03-27 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1,0500 | -4.386 | -5 | 6.718.670 | ||||
| 2025-04-30 | 2025-03-27 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 0,0900 | 50.873 | 5 | 6.723.056 | ||||
| 2024-01-04 | 3 | Atkins Michael B. | HOWL | Common Stock | D | 14.419 | ||||||||
| 2023-01-10 | 2023-01-06 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | HOWL | Common Stock | I | 2,2100 | 1.853.000 | 4.095 | 5.701.056 | ||||
| 2022-01-18 | 2022-01-06 | 4 | Leonard Reid | HOWL | Stock Option (Right to Buy) | D | 11,55 | 70.967 | 70.967 | |||||
| 2022-01-18 | 2022-01-06 | 4 | Isaacs Randi | HOWL | Stock Option (right to buy) | D | 11,55 | 79.516 | 79.516 | |||||
| 2022-01-18 | 2022-01-06 | 4 | Trost Timothy W. | HOWL | Stock Option (right to buy) | D | 11,55 | 65.960 | 65.960 | |||||
| 2022-01-18 | 2022-01-06 | 4 | HICKLIN DANIEL J | HOWL | Stock Option (right to buy) | D | 11,55 | 215.888 | 215.888 | |||||
| 2022-01-18 | 2022-01-06 | 4 | Lubman Ellen | HOWL | Stock Option (right to buy) | D | 11,55 | 51.088 | 51.088 | |||||
| 2022-01-18 | 2022-01-06 | 4 | Karunatilake Chulani | HOWL | Stock Option (right to buy) | D | 11,55 | 34.258 | 34.258 | |||||
| 2022-01-14 | 2022-01-12 | 4 | Seidel-Dugan Cynthia | HOWL | Stock Option (right to buy) | D | 4,77 | -15.532 | 83.631 | |||||
| 2022-01-14 | 2022-01-12 | 4 | Seidel-Dugan Cynthia | HOWL | Stock Option (right to buy) | D | 1,56 | -24.199 | 36.937 | |||||
| 2022-01-14 | 2022-01-12 | 4 | Seidel-Dugan Cynthia | HOWL | Common Stock | D | 4,7700 | 15.532 | 74 | 164.888 | ||||
| 2022-01-14 | 2022-01-12 | 4 | Seidel-Dugan Cynthia | HOWL | Common Stock | D | 1,5600 | 24.199 | 38 | 149.356 | ||||
| 2022-01-14 | 2022-01-06 | 4 | Seidel-Dugan Cynthia | HOWL | Stock Option (right to buy) | D | 11,55 | 79.516 | 79.516 | |||||
| 2022-01-04 | 2021-12-30 | 4 | Leonard Reid | HOWL | Stock Option (Right to Buy) | D | 1,56 | -14.102 | 47.034 | |||||
| 2022-01-04 | 2021-12-30 | 4 | Leonard Reid | HOWL | Common Stock | D | 1,5600 | 14.102 | 22 | 14.102 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Leonard Reid By The Leonard Revocable Living Trust | HOWL | Common Stock | I | 13,9736 | -135 | -2 | 122.157 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Leonard Reid By The Leonard Revocable Living Trust | HOWL | Common Stock | I | 13,3875 | -2.865 | -38 | 122.292 | ||||
| 2021-11-01 | 2021-10-28 | 4 | Chatterjee Meeta | HOWL | Stock Option (right to buy) | D | 15,97 | 23.200 | 23.200 | |||||
| 2021-07-02 | 2021-07-01 | 4 | Karunatilake Chulani | HOWL | Stock Option (right to buy) | D | 19,23 | 272.000 | 272.000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 13,3700 | 9.285 | 124 | 4.291.881 | ||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 12,9500 | 7.958 | 103 | 4.282.596 | ||||
| 2021-06-16 | 2021-06-14 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 12,7500 | 306.055 | 3.902 | 4.274.638 | ||||
| 2021-05-28 | 2021-05-27 | 4 | Sherman Michael A. | HOWL | Stock Option (right to buy) | D | 14,63 | 23.200 | 23.200 | |||||
| 2021-05-06 | 2021-05-04 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Series B Preferred Stock | I | -2.930.482 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Series B Preferred Stock | I | -16.606.068 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 16,0000 | 105.788 | 1.693 | 443.825 | ||||
| 2021-05-06 | 2021-05-04 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 338.037 | 338.037 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 16,0000 | 1.609.212 | 25.747 | 3.524.758 | ||||
| 2021-05-06 | 2021-05-04 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | HOWL | Common Stock | I | 1.915.546 | 1.915.546 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | GADICKE ANSBERT | HOWL | Series B Preferred Stock | I | -12.899.925 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | GADICKE ANSBERT | HOWL | Series A Preferred Stock | I | -38.817.998 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 16,0000 | 245.000 | 3.920 | 6.672.183 | ||||
| 2021-05-06 | 2021-05-04 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 1.488.033 | 6.427.183 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | GADICKE ANSBERT | HOWL | Common Stock | I | 4.477.742 | 4.939.150 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | MPM BioVentures 2014, L.P. | HOWL | Series B Preferred Stock | I | -6.621.546 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | MPM BioVentures 2014, L.P. | HOWL | Series A Preferred Stock | I | -19.925.321 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 16,0000 | 125.759 | 2.012 | 3.187.998 | ||||
| 2021-05-06 | 2021-05-04 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 763.809 | 3.062.239 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | MPM BioVentures 2014, L.P. | HOWL | Common Stock | I | 2.298.430 | 2.298.430 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | EVNIN LUKE | HOWL | Series B Preferred Stock | I | -7.939.970 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | EVNIN LUKE | HOWL | Series A Preferred Stock | I | -23.892.677 | 0 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 16,0000 | 150.799 | 2.413 | 4.284.172 | ||||
| 2021-05-06 | 2021-05-04 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 915.892 | 4.133.373 | ||||||
| 2021-05-06 | 2021-05-04 | 4 | EVNIN LUKE | HOWL | Common Stock | I | 2.756.073 | 3.217.481 | ||||||
| 2021-05-06 | 2020-12-23 | 4 | EVNIN LUKE | HOWL | Series B Preferred Stock | I | 7.939.970 | 7.939.970 | ||||||
| 2021-05-05 | 2021-05-04 | 4 | HBM Healthcare Investments (Cayman) Ltd. | HOWL | Series B Preferred Stock | D | 5.426.819 | 0 | ||||||
| 2021-05-05 | 2021-05-04 | 4 | HBM Healthcare Investments (Cayman) Ltd. | HOWL | Common Stock | D | 625.995 | 625.995 | ||||||
| 2021-05-04 | 2021-04-30 | 4 | DiRocco Derek | HOWL | Stock Option (right to buy) | D | 16,00 | 23.200 | 23.200 | |||||
| 2021-05-04 | 2021-05-04 | 4 | Asanuma Sakae | HOWL | Series B Preferred Stock | I | -3.797.921 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Asanuma Sakae | HOWL | Series A Preferred Stock | I | -11.428.570 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Asanuma Sakae | HOWL | Common Stock | I | 16,0000 | 312.500 | 5.000 | 2.068.909 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Asanuma Sakae | HOWL | Common Stock | I | 438.098 | 1.756.409 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Asanuma Sakae | HOWL | Common Stock | I | 1.318.311 | 1.318.311 | ||||||
| 2021-05-04 | 2020-12-23 | 4 | Asanuma Sakae | HOWL | Series B Preferred Stock | I | 0,9214 | 3.797.921 | 3.499 | 3.797.921 | ||||
| 2021-05-04 | 2021-04-30 | 4 | Trost Timothy W. | HOWL | Stock Option (right to buy) | D | 16,00 | 54.756 | 54.756 | |||||
| 2021-05-04 | 2021-02-12 | 4 | Trost Timothy W. | HOWL | Stock Option (right to buy) | D | 5,98 | 247.812 | 247.812 | |||||
| 2021-05-04 | 2021-05-04 | 4 | Arkin Bio Ventures 2 L.P. | HOWL | Series B Preferred Stock | I | -3.560.551 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Arkin Bio Ventures 2 L.P. | HOWL | Series A Preferred Stock | I | -10.714.284 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Arkin Bio Ventures 2 L.P. | HOWL | Common Stock | I | 16,0000 | 400.000 | 6.400 | 2.046.634 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Arkin Bio Ventures 2 L.P. | HOWL | Common Stock | I | 410.717 | 1.646.634 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Arkin Bio Ventures 2 L.P. | HOWL | Common Stock | I | 1.235.917 | 1.235.917 | ||||||
| 2021-05-04 | 2021-04-30 | 4 | Seidel-Dugan Cynthia | HOWL | Stock Option (right to buy) | D | 16,00 | 57.908 | 57.908 | |||||
| 2021-05-04 | 2020-12-08 | 4 | Seidel-Dugan Cynthia | HOWL | Stock Option (right to buy) | D | 4,77 | 99.163 | 99.163 | |||||
| 2021-05-04 | 2021-05-04 | 4 | Taiho Ventures LLC | HOWL | Series B Preferred Stock | D | -3.797.921 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Taiho Ventures LLC | HOWL | Series A Preferred Stock | D | -11.428.570 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Taiho Ventures LLC | HOWL | Common Stock | D | 16,0000 | 312.500 | 5.000 | 2.068.909 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Taiho Ventures LLC | HOWL | Common Stock | D | 438.098 | 1.756.409 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Taiho Ventures LLC | HOWL | Common Stock | D | 1.318.311 | 1.318.311 | ||||||
| 2021-05-04 | 2021-04-30 | 4 | Leonard Reid | HOWL | Stock Option (right to buy) | D | 16,00 | 27.311 | 27.311 | |||||
| 2021-05-04 | 2020-12-08 | 4 | Leonard Reid | HOWL | Stock Option (right to buy) | D | 4,77 | 99.163 | 99.163 | |||||
| 2021-05-04 | 2021-05-04 | 4 | Longwood Fund III GP, LLC | HOWL | Series B Preferred Stock | I | -3.085.811 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Longwood Fund III GP, LLC | HOWL | Series A Preferred Stock | I | -9.285.714 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Longwood Fund III GP, LLC | HOWL | Common Stock | I | 16,0000 | 250.000 | 4.000 | 1.677.082 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Longwood Fund III GP, LLC | HOWL | Common Stock | I | 355.955 | 1.427.082 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Longwood Fund III GP, LLC | HOWL | Common Stock | I | 1.071.127 | 1.071.127 | ||||||
| 2021-05-04 | 2021-04-30 | 4 | Lubman Ellen | HOWL | Stock Option (right to buy) | D | 16,00 | 48.455 | 48.455 | |||||
| 2021-05-04 | 2020-12-08 | 4 | Lubman Ellen | HOWL | Stock Option (right to buy) | D | 4,77 | 118.781 | 118.781 | |||||
| 2021-05-04 | 2020-08-03 | 4 | Lubman Ellen | HOWL | Stock Option (right to buy) | D | 1,56 | 145.531 | 145.531 | |||||
| 2021-05-04 | 2021-05-04 | 4 | UPMC | HOWL | Series B Preferred Stock | D | -2.373.701 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | UPMC | HOWL | Series A Preferred Stock | D | -7.142.857 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | UPMC | HOWL | Common Stock | D | 273.811 | 1.097.756 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | UPMC | HOWL | Common Stock | D | 823.945 | 823.945 | ||||||
| 2021-05-04 | 2021-04-30 | 4 | Morrison Briggs | HOWL | Stock Option (right to buy) | D | 16,00 | 23.200 | 23.200 | |||||
| 2021-05-04 | 2021-05-04 | 4 | Lazarus Alon | HOWL | Series B Preferred Stock | I | -3.560.551 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Lazarus Alon | HOWL | Series A Preferred Stock | I | -10.714.284 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Lazarus Alon | HOWL | Common Stock | I | 16,0000 | 400.000 | 6.400 | 2.046.634 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Lazarus Alon | HOWL | Common Stock | I | 410.717 | 1.646.634 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Lazarus Alon | HOWL | Common Stock | I | 1.235.917 | 1.235.917 | ||||||
| 2021-05-04 | 2021-04-30 | 4 | Lazarus Alon | HOWL | Stock Option (right to buy) | D | 16,00 | 23.200 | 23.200 | |||||
| 2021-05-04 | 2020-12-23 | 4 | Lazarus Alon | HOWL | Series B Preferred Stock | I | 0,9214 | 3.560.551 | 3.281 | 3.560.551 | ||||
| 2021-05-04 | 2021-04-30 | 4 | Isaacs Randi | HOWL | Stock Option (right to buy) | D | 16,00 | 56.786 | 56.786 | |||||
| 2021-05-04 | 2020-12-08 | 4 | Isaacs Randi | HOWL | Stock Option (right to buy) | D | 4,77 | 140.208 | 140.208 | |||||
| 2021-05-04 | 2020-11-09 | 4 | Isaacs Randi | HOWL | Stock Option (right to buy) | D | 3,03 | 176.966 | 176.966 | |||||
| 2021-05-04 | 2021-04-30 | 4 | HICKLIN DANIEL J | HOWL | Stock Option (right to buy) | D | 16,00 | 155.416 | 155.416 | |||||
| 2021-05-04 | 2020-12-08 | 4 | HICKLIN DANIEL J | HOWL | Stock Option (right to buy) | D | 4,77 | 727.377 | 727.377 | |||||
| 2021-05-04 | 2021-05-04 | 4 | Sphera Global Healthcare Management LP | HOWL | Series B Preferred Stock | I | -2.713.410 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Sphera Global Healthcare Management LP | HOWL | Common Stock | I | 16,0000 | 475.000 | 7.600 | 787.997 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Sphera Global Healthcare Management LP | HOWL | Common Stock | I | 312.997 | 312.997 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Flynn James E Through Deerfield Partners, L.P. | HOWL | Series B Preferred Stock | I | -15.195.094 | 0 | ||||||
| 2021-05-04 | 2021-05-04 | 4 | Flynn James E Through Deerfield Partners, L.P. | HOWL | Common Stock | I | 16,0000 | 800.000 | 12.800 | 2.552.787 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Flynn James E Through Deerfield Partners, L.P. | HOWL | Common Stock | I | 1.752.787 | 1.752.787 | ||||||
| 2021-05-03 | 2021-04-30 | 4 | EVNIN LUKE | HOWL | Stock Option (Right to Buy) | D | 16,00 | 23.200 | 23.200 | |||||
| 2021-04-29 | 3 | MPM Oncology Impact Management GP LLC | HOWL | Common Stock | I | 461.408 | ||||||||
| 2021-04-29 | 3 | EVNIN LUKE | HOWL | Common Stock | I | 461.408 | ||||||||
| 2021-04-29 | 3 | Morrison Briggs | HOWL | Common Stock | D | 15.523 | ||||||||
| 2021-04-29 | 3 | Seidel-Dugan Cynthia | HOWL | Common Stock | D | 125.157 | ||||||||
| 2021-04-29 | 3 | Leonard Reid Through The Leonard Revocable Living Trust | HOWL | Common Stock | I | 125.157 | ||||||||
| 2021-04-29 | 3 | HICKLIN DANIEL J | HOWL | Common Stock | D | 647.047 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
